Fenwick & West represented Coinbase Global, Inc. in the offering. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Shockwave Medical, Inc. in the transaction. Shockwave Medical, Inc. (Nasdaq: SWAV) announced its $750 million offering of 1.00% convertible senior notes due 2028...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Archer Aviation Inc. in the transaction. Archer Aviation Inc. (NYSE: ACHR) announced a $215 million equity investment from Stellantis (NYSE: STLA), Boeing (NYSE:...
You must be a Standard 1 Year member to access this content.
Paul, Weiss, Rifkind, Wharton & Garrison LLP is advising MediPacific, Inc., while Fenwick & West LLP is advising Pardes Biosciences, Inc. in the transaction. MediPacific, Inc.,...
You must be a Standard 1 Year member to access this content.
Fenwick advised DexCom on the offering, while Davis Polk advised the representatives of the initial purchasers and the counterparties to the capped call transactions. DexCom, Inc....
You must be a Standard 1 Year member to access this content.
Fenwick represented Third Harmonic Bio, Inc. on the deal. Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Nextdoor, while Latham & Watkins LLP represented KVSB. Simpson Thacher represented Evercore Group L.L.C. and Morgan Stanley & Co. LLC on...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Coinbase Global on the deal. Coinbase Global, Inc. (Nasdaq: COIN), a leading provider of end-to-end financial infrastructure and technology for the...
You must be a Standard 1 Year member to access this content.
